Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation

被引:42
|
作者
Gilbert, Jessica R. [1 ]
Zarate, Carlos A., Jr. [1 ]
机构
[1] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, 10 Ctr Dr,MSC 1282, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Ketamine; Electrophysiology; Gamma; Long-term potentiation; Dynamic causal modeling; NMDA RECEPTOR BLOCKADE; D-ASPARTATE ANTAGONIST; EVOKED-POTENTIALS; OSCILLATIONS; DISORDER; INTERNEURONS; MECHANISMS; FREQUENCY; EFFICACY; TRIAL;
D O I
10.1016/j.pbb.2020.172856
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Over the last two decades, the discovery of ketamine's antidepressant properties has galvanized research into the neurobiology of treatment-resistant depression. Nevertheless, the mechanism of action underlying antidepressant response to ketamine remains unclear. This study reviews electrophysiological studies of ketamine's effects in individuals with depression as well as healthy controls, with a focus on two putative markers of synaptic potentiation: gamma oscillations and long-term potentiation. The review focuses on: 1) measures of gamma oscillations and power and their relationship to both acute, psychotomimetic drug effects as well as delayed antidepressant response in mood disorders; 2) changes in long-term potentiation as a promising measure of synaptic potentiation following ketamine administration; and 3) recent efforts to model antidepressant response to ketamine using novel computational modeling techniques, in particular the application of dynamic causal modeling to electrophysiological data. The latter promises to better characterize the mechanisms underlying ketamine's antidepressant effects.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] CASE SERIES: THE BENEFIT AND TOLERANCE OF LONG-TERM MAINTENANCE KETAMINE INFUSION FOR TREATMENT-RESISTANT DEPRESSION IN ADOLESCENT PATIENTS
    Wakimoto, Yuji
    Kendrick, Jeremy
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S248 - S248
  • [32] Gene Expression and Ketamine Response in Subjects With Treatment-Resistant Depression
    Mohazzab-Hosseinian, Sahra
    Kadriu, Bashkim
    Zandi, Peter
    Zarate, Carlos
    Goes, Fernando
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 318 - 319
  • [33] Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
    Niciu, Mark J.
    Luckenbaugh, David A.
    Ionescu, Dawn F.
    Guevara, Sara
    Machado-Vieira, Rodrigo
    Richards, Erica M.
    Brutsche, Nancy E.
    Nolan, Neal M.
    Zarate, Carlos A., Jr.
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (05) : E417 - E423
  • [34] Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression
    Lineham, Alice
    Avila-Quintero, Victor J.
    Bloch, Michael H.
    Dwyer, Jennifer
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2024, 34 (02) : 73 - 79
  • [35] In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response
    Holsinger, Tracey
    Riordan, Paul
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (09) : JC105 - JC105
  • [36] Ketamine inhibits long-term potentiation and promotes long-term depression in the nucleus accumbens
    Yao, N.
    Svenningson, P.
    Chergui, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S19 - S20
  • [37] LONG-TERM COST-EFFECTIVENESS OF ESKETAMINE FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION
    Touchette, D.
    Boyer, N.
    Atlas, S. J.
    Agboola, F. O.
    Talon, B.
    Schultz, B.
    Kumar, V. M.
    Fazioli, K.
    Fluetsch, N.
    Rind, D.
    VALUE IN HEALTH, 2019, 22 : S683 - S683
  • [38] Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression
    Ranjan, R
    Meltzer, HY
    BIOLOGICAL PSYCHIATRY, 1996, 40 (04) : 253 - 258
  • [39] Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
    Cristan A. Farmer
    Jessica R. Gilbert
    Ruin Moaddel
    Jomy George
    Lilian Adeojo
    Jacqueline Lovett
    Allison C. Nugent
    Bashkim Kadriu
    Peixiong Yuan
    Todd D. Gould
    Lawrence T. Park
    Carlos A. Zarate
    Neuropsychopharmacology, 2020, 45 : 1398 - 1404
  • [40] Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
    Farmer, Cristan A.
    Gilbert, Jessica R.
    Moaddel, Ruin
    George, Jomy
    Adeojo, Lilian
    Lovett, Jacqueline
    Nugent, Allison C.
    Kadriu, Bashkim
    Yuan, Peixiong
    Gould, Todd D.
    Park, Lawrence T.
    Zarate, Carlos A., Jr.
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (08) : 1398 - 1404